Literature DB >> 17657219

Gene structure, expression profiling and mutation analysis of the tumour suppressor SHIP1 in Caucasian acute myeloid leukaemia.

D C Gilby, A C Goodeve, P R Winship, P J Valk, R Delwel, J T Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17657219     DOI： 10.1038/sj.leu.2404864

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.

Authors:  Patrick Ehm; Marcus M Nalaskowski; Torsten Wundenberg; Manfred Jücker
Journal:  Nucleus       Date:  2015-02-27       Impact factor: 4.197

Review 2.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

3.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

Authors:  Christina Gewinner; Zhigang C Wang; Andrea Richardson; Julie Teruya-Feldstein; Dariush Etemadmoghadam; David Bowtell; Jordi Barretina; William M Lin; Lucia Rameh; Leonardo Salmena; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

4.  Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.

Authors:  Emily Marie Mangialardi; Keyue Chen; Brittany Salmon; Jean Vacher; Leonardo Salmena
Journal:  Oncotarget       Date:  2019-10-29

Review 5.  Phosphatidylinositolphosphate phosphatase activities and cancer.

Authors:  Simon A Rudge; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2015-08-24       Impact factor: 5.922

6.  Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.

Authors:  Veronika Ecker; Martina Stumpf; Lisa Brandmeier; Tanja Neumayer; Lisa Pfeuffer; Thomas Engleitner; Ingo Ringshausen; Nina Nelson; Manfred Jücker; Stefan Wanninger; Thorsten Zenz; Clemens Wendtner; Katrin Manske; Katja Steiger; Roland Rad; Markus Müschen; Jürgen Ruland; Maike Buchner
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

7.  PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.

Authors:  Yan Ye; Lei Jin; James S Wilmott; Wang Lai Hu; Benafsha Yosufi; Rick F Thorne; Tao Liu; Helen Rizos; Xu Guang Yan; Li Dong; Kwang Hong Tay; Hsin-Yi Tseng; Su Tang Guo; Charles E de Bock; Chen Chen Jiang; Chun Yan Wang; Mian Wu; Lin Jie Zhang; Peter Hersey; Richard A Scolyer; Xu Dong Zhang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.

Authors:  Meng Na Chi; Su Tang Guo; James S Wilmott; Xiang Yun Guo; Xu Guang Yan; Chun Yan Wang; Xiao Ying Liu; Lei Jin; Hsin-Yi Tseng; Tao Liu; Amanda Croft; Hubert Hondermarck; Richard A Scolyer; Chen Chen Jiang; Xu Dong Zhang
Journal:  Oncotarget       Date:  2015-11-24

Review 9.  Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.

Authors:  Botle Precious Setlai; Rodney Hull; Meshack Bida; Chrisna Durandt; Thanyani Victor Mulaudzi; Aristotelis Chatziioannou; Zodwa Dlamini
Journal:  Biomedicines       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.